Trial Profile
Safety, Tolerability and Pharmacokinetics of Intravenous Oseltamivir: Single Dose Phase I Study in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2012
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors Roche
- 10 Jul 2012 New trial record